Identifying a New MicroRNA Signature As a Prognostic Biomarker in Colon Cancer

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Feb 13

PMID 32049961

Citations 21

Authors

Yunxia Lv

Jinzhong Duanmu

Xiaorui Fu

Taiyuan Li

Qunguang Jiang

Affiliations

Soon will be listed here.

Abstract

Background: The aim was to identify a novel prognostic miRNA signature for colon cancer (CC) in silico.

Methods: Data on the expression of miRNAs and relevant clinical information for 407 patients were obtained from The Cancer Genome Atlas (TCGA), and the samples were randomly split into a validation set (n = 203) and training set (n = 204). The differential expression of miRNAs between normal tissues and patients with CC was analyzed. We detected a miRNA expression signature in the training dataset by using a Cox proportional hazard regression model. Then, we verified the signature in the validation set. Association of the miRNA signature with overall survival was assessed in the validation cohort and combined cohort by log-rank test and based on Kaplan-Meier curves. The receiver operating characteristic and disease-free survival analyses were performed to evaluate the miRNA signature of CC in the combined cohort. Multivariate and univariate Cox analyses related to survival for the miRNA signature were performed, and a nomogram was built as a prognostic model for CC. To explore the function of target genes of the miRNA signature, Gene Ontology analysis and Kyoto Encyclopedia of Genes and Genomes pathway analysis were used.

Results: Between the matched normal tissues and colon cancer tissues, 267 differentially expressed miRNAs were detected, and a single-factor CoxPH model showed that 13 miRNAs were related to overall survival in the training cohort. Then, a five-miRNA signature was identified using a CoxPH regression model with multiple factors. The five-miRNA signature had significant prognostic value in the training cohort and was validated in the validation cohort and combined cohort. A total of 193 target genes of the miRNA signature were identified. According to the results of functional analysis of the target genes, the signaling pathways MAPK, AMPK and PI3K-Akt, focal adhesion, and microRNAs in cancer were remarkably enriched.

Conclusion: A five-miRNA signature had increased prognostic value for CC, which may provide important biological insights for the discovery and development of molecular predictors to improve the prognosis of patients with CC.

Citing Articles

Bioinformatics analysis of miR-2861 and miR-5011-5p that function as potential tumor suppressors in colorectal carcinogenesis.

Aytekin A, Kadakal H, Mihcioglu D, Gurer T BMC Med Genomics. 2025; 18(1):1.

PMID: 39748239 PMC: 11697744. DOI: 10.1186/s12920-024-02080-6.

Multiomics dynamic learning enables personalized diagnosis and prognosis for pancancer and cancer subtypes.

Lu Y, Peng R, Dong L, Xia K, Wu R, Xu S Brief Bioinform. 2023; 24(6).

PMID: 37889117 PMC: 10605059. DOI: 10.1093/bib/bbad378.

Thymoquinone Potentially Modulates the Expression of Key Onco- and Tumor Suppressor miRNAs in Prostate and Colon Cancer Cell Lines: Insights from PC3 and HCT-15 Cells.

Osorio-Perez S, Estrada-Meza C, Ruiz-Manriquez L, Arvizu-Espinosa M, Srivastava A, Sharma A Genes (Basel). 2023; 14(9).

PMID: 37761870 PMC: 10531155. DOI: 10.3390/genes14091730.

Bioinformatics and Expression Analyses of miR-639, miR-641, miR-1915-3p and miR-3613-3p in Colorectal Cancer Pathogenesis.

Avsar R, Gurer T, Aytekin A J Cancer. 2023; 14(13):2399-2409.

PMID: 37670968 PMC: 10475367. DOI: 10.7150/jca.86974.

Effect of tumor-associated macrophages on the pyroptosis of breast cancer tumor cells.

Ji X, Huang X, Li C, Guan N, Pan T, Dong J Cell Commun Signal. 2023; 21(1):197.

PMID: 37542283 PMC: 10401873. DOI: 10.1186/s12964-023-01208-y.

References

Wang C, Deng F, Li H, Wang D, Zhang W, Ding L . MiR-101: a potential therapeutic target of cancers. Am J Transl Res. 2019; 10(11):3310-3321. PMC: 6291716. View

Valladares-Ayerbes M, Blanco M, Haz M, Medina V, Iglesias-Diaz P, Lorenzo-Patino M . Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer. Int J Oncol. 2011; 39(5):1253-64. DOI: 10.3892/ijo.2011.1112. View

Xu M, Kuang Y, Wang M, Han X, Yang Q . A microRNA expression signature as a predictor of survival for colon adenocarcinoma. Neoplasma. 2016; 64(1):56-64. DOI: 10.4149/neo_2017_107. View

Yu Y, Kanwar S, Patel B, Oh P, Nautiyal J, Sarkar F . MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis. 2011; 33(1):68-76. PMC: 3276336. DOI: 10.1093/carcin/bgr246. View

Wang S, Yang M, Wang X, Lin J, Ding Y . Increased expression of miRNA-182 in colorectal carcinoma: an independent and tissue-specific prognostic factor. Int J Clin Exp Pathol. 2014; 7(6):3498-503. PMC: 4097234. View

Nielsen B, Jorgensen S, Fog J, Sokilde R, Christensen I, Hansen U . High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis. 2010; 28(1):27-38. PMC: 2998639. DOI: 10.1007/s10585-010-9355-7. View

Hasegawa T, Glavich G, Pahuski M, Short A, John Semmes O, Yang L . Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate. Mol Cancer Res. 2018; 16(4):669-681. PMC: 5882523. DOI: 10.1158/1541-7786.MCR-17-0321. View

Chao A, Lin C, Lee Y, Tsai C, Wei P, Hsueh S . Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Oncogene. 2011; 31(6):764-75. DOI: 10.1038/onc.2011.269. View

Wang Z, Zhong M, Bian Y, Mu Y, Qin S, Yu M . MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer. Oncotarget. 2016; 7(28):44266-44276. PMC: 5190094. DOI: 10.18632/oncotarget.10023. View

10.

Xiao G, Tang H, Wei W, Li J, Ji L, Ge J . Aberrant Expression of MicroRNA-15a and MicroRNA-16 Synergistically Associates with Tumor Progression and Prognosis in Patients with Colorectal Cancer. Gastroenterol Res Pract. 2014; 2014:364549. PMC: 4236961. DOI: 10.1155/2014/364549. View

11.

Deng S, Calin G, Croce C, Coukos G, Zhang L . Mechanisms of microRNA deregulation in human cancer. Cell Cycle. 2008; 7(17):2643-6. DOI: 10.4161/cc.7.17.6597. View

12.

Zhang W, Zhang T, Jin R, Zhao H, Hu J, Feng B . MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer. J Exp Clin Cancer Res. 2015; 33:113. PMC: 4304202. DOI: 10.1186/s13046-014-0113-6. View

13.

Calin G, Croce C . MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6(11):857-66. DOI: 10.1038/nrc1997. View

14.

Zhang J, Chong C, Chen G, Lai P . A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma. PLoS One. 2015; 10(6):e0128628. PMC: 4457814. DOI: 10.1371/journal.pone.0128628. View

15.

Song L, Zhang W, Chang Z, Pan Y, Zong H, Fan Q . PU.1 Is Identified as a Novel Metastasis Suppressor in Hepatocellular Carcinoma Regulating the miR-615-5p/IGF2 Axis. Asian Pac J Cancer Prev. 2015; 16(9):3667-71. DOI: 10.7314/apjcp.2015.16.9.3667. View

16.

Gao W, Gu Y, Li Z, Cai H, Peng Q, Tu M . miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. Oncogene. 2014; 34(13):1629-40. DOI: 10.1038/onc.2014.101. View

17.

Chandramouli A, Onyeagucha B, Mercado-Pimentel M, Stankova L, Shahin N, LaFleur B . MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers. Cancer Biol Ther. 2012; 13(3):175-83. PMC: 3336073. DOI: 10.4161/cbt.13.3.18874. View

18.

Feng B, Dong T, Wang L, Zhou H, Zhao H, Dong F . Colorectal cancer migration and invasion initiated by microRNA-106a. PLoS One. 2012; 7(8):e43452. PMC: 3422256. DOI: 10.1371/journal.pone.0043452. View

19.

Hwang W, Jiang J, Yang S, Huang T, Lan H, Teng H . MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol. 2014; 16(3):268-80. DOI: 10.1038/ncb2910. View

20.

Nishida N, Yamashita S, Mimori K, Sudo T, Tanaka F, Shibata K . MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. Ann Surg Oncol. 2012; 19(9):3065-71. DOI: 10.1245/s10434-012-2246-1. View